Quick Links

muhc

Lazy-eye disorder -- a promising therapeutic approach

Researchers use popular puzzle video game to treat adult amblyopia
Mon, 2013-04-22 14:57

A research team led by Dr. Robert Hess from McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) has used the popular puzzle video game Tetris in an innovative approach to treat adult amblyopia, commonly known as “lazy eye”. By distributing information between the two eyes in a complementary fashion, the video game trains both eyes to work together, which is counter to previous treatments for the disorder (e.g. patching).

Contact Information

Contact: Julie Robert
Organization: McGill University Health Centre
Email:
Office Phone: 514 934 1934 ext. 71381

Secondary Contact Information

Contact: Cynthia Lee
Organization: Media Relations
Office Phone: 514.398.6754
Category:
Source Site: /newsroom

Thank you to Prof. Rima Rozen

Thu, 2013-01-31 14:26

After 14 years in senior university administration, Dr. Rima Rozen will return full-time to her work in research and teaching as the James McGill Professor of Human Genetics and Pediatrics, when her current term as Associate Vice-Principal (Research and International Relations) ends on January 31, 2013. 

Source Site: /research

MUHC Psychiatry Grand Rounds / RI-MUHC Mental Illness and Addiction Axis -- Neurobiology of Stress, Depression, and Antidepressants: Remodeling Synaptic Connections

Fri, 2013-02-15 11:00 - 12:30
Allan Memorial Inst. Hospital : South Seminar Room P1.082, 1025 avenue des Pins Montreal Quebec Canada , H3A 1A1

Special Guest Speaker: Ronald Duman Ph.D.
Professor of Psychiatry and Neurobiology, Department of Psychiatry, Yale School of Medicine
Neurobiology of Stress, Depression, and Antidepressants: Remodeling Synaptic Connections

Contact Information

Contact: Ms. Katie Boodhoo, B.Sc
Organization: Research Assistant, Addictions Unit
Email:
Office Phone: 514-934-1934 ext 34588
Source Site: /psychiatry

Lupus drugs carry no significant cancer risk

Montreal, January 24, 2013 – People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). This landmark study, which was published in Annals of the Rheumatic Diseases this month, addresses long-standing fears of a link between lupus medication and cancer.
Fri, 2013-01-25 12:42

Systemic lupus erythematosus (SLE), commonly known as lupus, is an autoimmune disease in which the body's immune system attacks healthy tissue such as the skin, joints, kidneys and the brain, leading to inflammation and lesions. The disease affects about 1 in 2000 Canadians, particularly women. Previous research has suggested that lupus patients have an increased risk of developing cancer, particularly lymphoma.  Lymphoma is a type of blood cancer that occurs when cells called lymphocytes, which usually help protect the body from infection and disease, begin growing and multiplying uncontrollably leading to tumor growth.

Contact Information

Contact: Julie Robert
Organization: Communications – Research, Public Affairs & Strategic Planning, McGill University Health Centre
Email:
Office Phone: 514-934-1934 (ext. 71381)
Category:
Source Site: /newsroom

New Chief of the Department of Psychiatry at the McGill University Health Centre

Mon, 2012-12-03 14:13

Message from Normand Rinfret, Director General and CEO


It is with great pleasure that we announce the appointment of Dr. Nadia Szkrumelak to the position of Chief of the Department of Psychiatry.


Dr. Szkrumelak is a graduate of McGill University, and has been a member of the Department of Psychiatry at the MUHC since 1984.

Source Site: /psychiatry

MUHC Psychiatry Grand Rounds -- The New MD CM Curriculum

Fri, 2012-11-09 11:00 - 12:30
Allan Memorial Inst. Hospital : South Seminar Room P1.082, 1025 avenue des Pins Montreal Quebec Canada , H3A 1A1

We are pleased to present

 

ROBERT PRIMAVESI, M.D.,FRCP(C), Associate Dean. Undergraduate Medical Education, Faculty of Medicine, McGill University

&

BETH-ANN CUMMINGS, M.D., FRCP(C), M.Sc., Clerkship Component Chair, Faculty of Medicine & Assistant Professor, Department of Medicine, McGill University

 

Contact Information

Contact: Tewfik Said, M.D., Co-ordinator
Organization: Psychiatry CME, MUHC
Office Phone: 514-934-1934 ext 34588
Source Site: /psychiatry

Treating ovarian cancer: new pathways through genetics

Montreal-based researchers discover genetics secrets of ovarian cancer tumours
Wed, 2012-09-26 11:10

A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease. A multi-disciplinary team led by the Research Institute of the McGill University Health Centre (RI MUHC), in collaboration with the Lady Davis Institute of the Jewish General Hospital and the University of Montreal Hospital Research Centre, has identified genetic patterns in ovarian cancer tumours that help to differentiate patients based on the length of their survival after initial surgery. The study was published in the journal PLOS ONE. 

Contact Information

Contact: Julie Robert
Organization: McGill University Health Centre
Email:
Office Phone: 514-934-1934 (ext. 71381)
Category:
Source Site: /newsroom